Company
United StatesDamien Sanderlin, MD, Houston, TX – FDA Inspections
Inspection records and compliance data for Damien Sanderlin, MD in Houston, Texas. 2 FDA inspections on record (2 OAI), last inspected July 18, 2012.
Company Profile
This profile covers Damien Sanderlin, MD based in Houston, Texas, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 2
- VAI
- 0
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
First inspected March 29, 2012. Last inspected July 18, 2012.
Most cited issue areas
- Investigator lack of informed consent1 inspection
- Investigator non-compliance with agreement/plan/regulations1 inspection
- No investigator protection - subject rights, safety, welfare1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 18, 2012 | OAI | Medical Devices & Rad Health · Bioresearch Monitoring | 790026 |
| March 29, 2012 | OAI | Biologics · Bioresearch Monitoring | 775234 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Damien Sanderlin, MD
FEI Number
3009417634
Address
Lone Star Clinical Research, 8240 Antoine Dr Ste 107, Houston, Texas 77088, United States
Country
United States
ID: ee882a7a-e0f5-4507-a51a-8796cab9d12f